Literature DB >> 20040920

Comorbidity and confounding in end-stage renal disease.

Stephen L Seliger1.   

Abstract

In the epidemiologic study of end-stage renal disease (ESRD), accurate adjustment for comorbidity is essential to controlling bias in the comparison of outcomes across groups of patients or dialysis facilities. Liu et al. derive and validate a novel comorbidity index using data from the United States Renal Data System. This novel index represents an important tool for observational research in ESRD but will not by itself overcome the potential problems of residual and unmeasured confounding in observational research.

Entities:  

Mesh:

Year:  2010        PMID: 20040920     DOI: 10.1038/ki.2009.431

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.

Authors:  Timmy Lee; Mae Thamer; Qian Zhang; Yi Zhang; Michael Allon
Journal:  Am J Nephrol       Date:  2016-05-11       Impact factor: 3.754

2.  Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Authors:  Timmy Lee; Mae Thamer; Yi Zhang; Qian Zhang; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.

Authors:  James B Wetmore; Jonathan D Mahnken; Sally K Rigler; Edward F Ellerbeck; Purna Mukhopadhyay; John A Spertus; Qingjiang Hou; Theresa I Shireman
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

4.  End-stage renal disease: a new comorbidity index for estimating mortality risk in ESRD.

Authors:  Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2010-07       Impact factor: 28.314

5.  Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

Authors:  Frederik Peters; Christina Westphal; Anneke Kramer; Ronny Westerman
Journal:  Front Public Health       Date:  2018-05-04

6.  Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis.

Authors:  Sally K Rigler; James B Wetmore; Jonathan D Mahnken; Lei Dong; Edward F Ellerbeck; Theresa I Shireman
Journal:  BMC Nephrol       Date:  2013-02-27       Impact factor: 2.388

7.  Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial.

Authors:  Ruchir Trivedi; George Fares; Victoria Barany Nunez; Ryan Campbell; Megyn Clement; Joseph Burleson; Jonathan Himmelfarb; Effie Ioannidou
Journal:  Trials       Date:  2018-07-11       Impact factor: 2.279

8.  A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.

Authors:  Yi-Chun Chen; Shang-Jyh Hwang; Chung-Yi Li; Chia-Pin Wu; Li-Chu Lin
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.